December 2, 2021
Via: European Pharmaceutical ReviewSanofi has announced that it entered into an agreement to acquire Origimm Biotechnology, an Austrian privately owned biotechnology company specialising in the discovery of virulent skin microbiome components and antigens from bacteria causing skin disease, such as acne. The transaction […]
March 30, 2023
March 28, 2023
March 23, 2023
March 16, 2023